FP7H2020HORIZON
Fondazione Telethon Ets
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 59
- As coordinator
- 29
- EU contribution (CORDIS)
- EUR 47,915,079
- Active
- 2008 to 2025
Projects
59 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| RAREFINDInternational Training for Doctoral Research on Advanced Gene and Cell Therapies | HORIZON | 2025 | Coordinator | Not stated |
| JOIN4ATMPMAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT | HORIZON | 2024 | Participant | EUR 150,000 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 1,401,160 |
| ProgRetEuropean Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases | HORIZON | 2024 | Participant | EUR 259,438 |
| IMMUTOLADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES | HORIZON | 2023 | Coordinator | EUR 1,336,720 |
| EP PerMedEuropean Partnership for Personalised Medicine | HORIZON | 2023 | Participant | EUR 54,750 |
| INCANTARTARGETING INHERITED CANCER SYNDROMES | HORIZON | 2023 | Coordinator | EUR 2,496,625 |
| EXPEDITEEXPanding AAV gene therapy by EDITing | HORIZON | 2023 | Coordinator | EUR 2,492,303 |
| X-PANDExploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application | HORIZON | 2022 | Third party | Not stated |
| RE-STOREPharmacological restoration of selective autophagy for the treatment of skeletal disorders | H2020 | 2021 | Coordinator | EUR 120,000 |
| IC2PerMedIntegrating China in the International Consortium for Personalised Medicine | H2020 | 2020 | Participant | EUR 250,938 |
| EASY-IPSa rapid and efficient method for generation of iPSC | H2020 | 2019 | Coordinator | EUR 150,000 |
| UPGRADEUnlocking Precision Gene Therapy | H2020 | 2019 | Coordinator | EUR 4,952,969 |
| inSightMoving a novel gene therapy paradigm to treat blindness to the market | H2020 | 2019 | Participant | EUR 42,375 |
| RESTORERESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients | H2020 | 2019 | Participant | EUR 52,500 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 1,010,694 |
| EpiTFebDeciphering the Transcriptional Logic of TFEB activation in cell identity and cancer | H2020 | 2018 | Coordinator | EUR 180,277 |
| CellKarmaDissecting the regulatory logic of cell fate reprogramming through integrative and single cell genomics | H2020 | 2018 | Coordinator | EUR 1,497,250 |
| StarTEuropean Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder | H2020 | 2018 | Participant | EUR 522,999 |
| UshTherClinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB | H2020 | 2018 | Coordinator | EUR 1,783,642 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.